Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 2
1990 2
1992 2
1993 2
1995 5
1996 3
1997 3
1998 6
1999 6
2000 5
2001 2
2002 8
2003 5
2004 3
2005 3
2006 5
2007 6
2008 7
2009 13
2010 16
2011 15
2012 16
2013 15
2014 13
2015 8
2016 14
2017 13
2018 20
2019 20
2020 24
2021 28
2022 28
2023 18
2024 24

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

326 results

Results by year

Filters applied: . Clear all
Page 1
Pillars of long-term antiretroviral therapy success.
Taramasso L, Andreoni M, Antinori A, Bandera A, Bonfanti P, Bonora S, Borderi M, Castagna A, Cattelan AM, Celesia BM, Cicalini S, Cingolani A, Cossarizza A, D'Arminio Monforte A, D'Ettorre G, Di Biagio A, Di Giambenedetto S, Di Perri G, Esposito V, Focà E, Gervasoni C, Gori A, Gianotti N, Guaraldi G, Gulminetti R, Lo Caputo S, Madeddu G, Maggi P, Marandola G, Marchetti GC, Mastroianni CM, Mussini C, Perno CF, Rizzardini G, Rusconi S, Santoro M, Sarmati L, Zazzi M, Maggiolo F. Taramasso L, et al. Among authors: zazzi m. Pharmacol Res. 2023 Oct;196:106898. doi: 10.1016/j.phrs.2023.106898. Epub 2023 Aug 28. Pharmacol Res. 2023. PMID: 37648103 Free article. Review.
Emergent HIV drug resistance in non-inferiority trials.
Ripamonti D, Zazzi M. Ripamonti D, et al. Among authors: zazzi m. Lancet HIV. 2023 Oct;10(10):e632-e634. doi: 10.1016/S2352-3018(23)00203-5. Epub 2023 Sep 12. Lancet HIV. 2023. PMID: 37714175 No abstract available.
Spectrum of Atazanavir-Selected Protease Inhibitor-Resistance Mutations.
Rhee SY, Boehm M, Tarasova O, Di Teodoro G, Abecasis AB, Sönnerborg A, Bailey AJ, Kireev D, Zazzi M, The EuResist Network Study Group, Shafer RW. Rhee SY, et al. Among authors: zazzi m. Pathogens. 2022 May 5;11(5):546. doi: 10.3390/pathogens11050546. Pathogens. 2022. PMID: 35631067 Free PMC article.
Enhancing care for people living with HIV: current and future monitoring approaches.
Maggiolo F, Bandera A, Bonora S, Borderi M, Calcagno A, Cattelan A, Cingolani A, Gianotti N, Lichtner M, Lo Caputo S, Madeddu G, Maggi P, Marchetti GC, Maserati R, Nozza S, Rusconi S, Zazzi M, Di Biagio A. Maggiolo F, et al. Among authors: zazzi m. Expert Rev Anti Infect Ther. 2021 Apr;19(4):443-456. doi: 10.1080/14787210.2021.1823217. Epub 2020 Oct 15. Expert Rev Anti Infect Ther. 2021. PMID: 33054479 Free article. Review.
Inflammation burden score in multidrug-resistant HIV-1 infection.
Clemente T, Caccia R, Galli L, Galli A, Poli A, Marchetti GC, Bandera A, Zazzi M, Santoro MM, Cinque P, Castagna A, Spagnuolo V; PRESTIGIO Study Group. Clemente T, et al. Among authors: zazzi m. J Infect. 2023 May;86(5):453-461. doi: 10.1016/j.jinf.2023.03.011. Epub 2023 Mar 11. J Infect. 2023. PMID: 36913985
326 results